Drug:
Reaction: GAIT DISTURBANCE
20260101 - 20261231
No. 1301 - 1400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1301 | 26700190 |
GB |
76 | 1 |
Death, Unevaluable event, Parkinson^s disease, Hallucination, visual, Decreased appetite, Dysstasia, Weight decreased, Mobility decreased, Gait disturbance, Hypotension, Oral fungal infection, Muscle rigidity, On and off phenomenon, Freezing phenomenon, Tremor, |
||||
| 1302 | 26700212 |
US |
31 | 1 |
Dizziness, Pain in extremity, Gait disturbance, Product administration error, |
||||
SPARSENTAN, |
||||
| 1303 | 26700415 |
31 | 1 | |
Gait disturbance, Hypocalcaemia, Hyperparathyroidism secondary, Mobility decreased, Bone pain, Osteomalacia, Stress fracture, Hypophosphataemia, |
||||
INFLIXIMAB-DYYB, |
||||
| 1304 | 26700495 |
1 | ||
Neuropathy peripheral, Hypoaesthesia, Gait disturbance, |
||||
CARBIDOPA AND LEVODOPA, |
||||
| 1305 | 26700552 |
MY |
30 | 2 |
Pulmonary embolism, Hypophagia, Vomiting, Cough, Dyspnoea, VIth nerve paralysis, Exophthalmos, Pericardial effusion, Respiratory failure, Metastasis, Cardiac arrest, Circulatory collapse, Lactic acidosis, Pneumonia, Sepsis, Tachypnoea, Swelling of eyelid, Diplopia, Gait disturbance, Palpitations, Vision blurred, Hypersensitivity, Breast mass, Heart rate increased, Pleural effusion, Abdominal distension, Cardiomegaly, Pelvic mass, Eye disorder, Ocular neoplasm, |
||||
ELTROMBOPAG OLAMINE, ELTROMBOPAG, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CALCIUM CARBONATE, ANTACID, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PANTOPRAZOLE, FUROSEMIDE, EPINEPHRINE, ADRENALINUM, EPINEPHRINE, ADRENALINUM, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, CALCIUM GLUCONATE, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, |
||||
| 1306 | 26700580 |
US |
1 | |
Multiple organ dysfunction syndrome, Immunodeficiency common variable, Leukopenia, Oesophageal candidiasis, Herpes simplex oesophagitis, Pharyngeal abscess, Listeriosis, Deafness, Pachymeningitis, Blindness, Colitis, Basal ganglia stroke, Gene mutation, Lymphopenia, Skin lesion, Granuloma, Skin ulcer, Infection, Papilloma viral infection, Arthralgia, Gait disturbance, Balance disorder, Arthritis, Ageusia, Anosmia, Hepatic lesion, Off label use, Product ineffective for unapproved use, |
||||
ETANERCEPT, METHOTREXATE SODIUM, PREDNISONE, INFLIXIMAB, HYDROXYCHLOROQUINE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, RIBAVIRIN, NITAZOXANIDE, TOFACITINIB CITRATE, |
||||
| 1307 | 26700688 |
US |
38 | 1 |
Pulmonary oedema, Tongue discomfort, Hypertension, Rash, Restless legs syndrome, Anxiety, Abdominal discomfort, Dyspnoea, Gait disturbance, Glossitis, Dysphagia, Oral discomfort, Intentional product use issue, Headache, Glossodynia, Vision blurred, Peripheral swelling, Heart rate increased, |
||||
LENVATINIB, LENVATINIB, LENVATINIB, ZOLEDRONIC ACID, ENOXAPARIN SODIUM, LOSARTAN, GABAPENTIN, ERGOCALCIFEROL, PRAMIPEXOLE DIHYDROCHLORIDE, |
||||
| 1308 | 26700742 |
CA |
62 | 1 |
Nephrolithiasis, Cholelithiasis, Acetabulum fracture, Loss of consciousness, Short-bowel syndrome, Steatorrhoea, Fall, Asthenia, Discomfort, Disorientation, Dizziness, Dyspnoea exertional, Gait disturbance, Humerus fracture, Pain, Renal disorder, Sensation of foreign body, Sensory disturbance, Taste disorder, Blood pressure increased, Blood potassium increased, |
||||
TACROLIMUS, MIRABEGRON, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DARBEPOETIN ALFA, BUPROPION, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CALCIUM, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ERGOCALCIFEROL, CYANOCOBALAMIN, GABAPENTIN, HYDROCORTISONE VALERATE, IRON, MIRTAZAPINE, OXYCODONE, PANTOPRAZOLE, PREDNISONE, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, URSODIOL, URSOSIOL, VITAMIN E, CITALOPRAM, CITALOPRAM HYDROBROMIDE, HYDROCORTISONE VALERATE, DARBEPOETIN ALFA, SODIUM ZIRCONIUM CYCLOSILICATE, |
||||
| 1309 | 26701005 |
US |
42 | 2 |
Gait disturbance, Back pain, Increased appetite, Abdominal pain upper, Vomiting, Weight increased, Diarrhoea, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 1310 | 26702458 |
68 | 1 | |
Anxiety, Suicidal ideation, Musculoskeletal stiffness, Reduced facial expression, Movement disorder, Gait disturbance, |
||||
OLANZAPINE, |
||||
| 1311 | 26689408 |
CA |
61 | 2 |
Colitis, Arthralgia, Decreased appetite, Crohn^s disease, Feeding disorder, Colonic fistula, Gait disturbance, |
||||
RISANKIZUMAB-RZAA, ADALIMUMAB-AFZB, ADALIMUMAB-AFZB, ADALIMUMAB-AFZB, PREDNISONE, |
||||
| 1312 | 26689495 |
CA |
43 | 2 |
Deep vein thrombosis postoperative, Gastrointestinal disorder, Dizziness, Decreased appetite, Glossodynia, Diarrhoea, Gait disturbance, Depression, Discomfort, Drug intolerance, General physical health deterioration, Dyspnoea, Facet joint syndrome, Dry mouth, Drug hypersensitivity, Dyspepsia, Grip strength decreased, Duodenal ulcer perforation, Confusional state, Delirium, Dislocation of vertebra, Gait inability, Overdose, Contraindicated product administered, Off label use, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RISEDRONATE SODIUM, RISEDRONATE SODIUM, PREGABALIN, OXYCODONE, OXYCODONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, APREMILAST, APREMILAST, APREMILAST, TOFACITINIB CITRATE, CELECOXIB, CELECOXIB, CELECOXIB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, APREMILAST, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, USTEKINUMAB, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
| 1313 | 26689569 |
CA |
68 | |
Ovarian cancer stage IV, Vaginal haemorrhage, Gait disturbance, Peripheral swelling, Pain in extremity, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
| 1314 | 26689586 |
EU |
83 | 2 |
Renal failure, Hypotension, Gait disturbance, Urinary tract infection, Syncope, |
||||
DOXAZOSIN MESYLATE, CLONIDINE, FUROSEMIDE, BISOPROLOL FUMARATE, ALLOPURINOL, |
||||
| 1315 | 26689991 |
US |
1 | |
Hallucination, Condition aggravated, Oedema peripheral, Contusion, Gait disturbance, Confusional state, |
||||
PIMAVANSERIN TARTRATE, CELECOXIB, CLOPIDOGREL, CLOPIDOGREL BISULFATE, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, FLUOXETINE HYDROCHLORIDE, LOSARTAN POTASSIUM, LOSARTAN, MECLIZINE HCL 12.5 MG, MECLIZINE HCL 25 MG, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HCL 25MG, MECLIZINE HCL 12.5MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MODAFINIL, MONTELUKAST, MUPIROCIN, MUPIROCIN CALCIUM, PANTOPRAZOLE, PREGABALIN, ROSUVASTATIN, BUPROPION HYDROCHLORIDE, |
||||
| 1316 | 26690105 |
EG |
48 | 1 |
Death, Neurological symptom, Limb discomfort, Fatigue, Head injury, Fall, Drug ineffective, Intentional product use issue, Incontinence, Back pain, Gait disturbance, Gait disturbance, Pain in extremity, |
||||
OCRELIZUMAB, |
||||
| 1317 | 26690342 |
US |
62 | 2 |
Rheumatoid arthritis, Gait disturbance, Blood pressure fluctuation, Fibromyalgia, Exostosis, Degenerative bone disease, Foot deformity, Fatigue, Bone pain, Pain in extremity, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 1318 | 26690447 |
72 | ||
Hypersomnia, Gait disturbance, |
||||
BRIVARACETAM, |
||||
| 1319 | 26690729 |
US |
2 | |
Serum sickness, Joint swelling, Joint stiffness, Arthralgia, Gait disturbance, Condition aggravated, |
||||
DUPILUMAB, |
||||
| 1320 | 26690845 |
US |
7 | 1 |
Gait disturbance, Pain in extremity, Arthralgia, Arthralgia, |
||||
DUPILUMAB, |
||||
| 1321 | 26690919 |
US |
75 | 1 |
Condition aggravated, Pain, Musculoskeletal stiffness, Peripheral swelling, Malaise, Pain in extremity, Dizziness, Gait disturbance, Myalgia, Arthralgia, |
||||
SARILUMAB, |
||||
| 1322 | 26691025 |
US |
62 | 1 |
Polyarthritis, Gait disturbance, Arthralgia, Pain, Joint swelling, Product use in unapproved indication, Drug ineffective, |
||||
SARILUMAB, SARILUMAB, SARILUMAB, |
||||
| 1323 | 26691040 |
US |
2 | |
Dyspnoea, Gait disturbance, Arthritis, Memory impairment, Asthma, |
||||
DUPILUMAB, ALBUTEROL SULFATE, AMMONIUM LACTATE, CARVEDILOL, FLUTICASONE PROPIONATE, LINACLOTIDE, MONTELUKAST, PANTOPRAZOLE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ERGOCALCIFEROL, |
||||
| 1324 | 26691143 |
US |
2 | |
Gait disturbance, Musculoskeletal stiffness, Peripheral swelling, Joint swelling, Pain, Influenza like illness, Myalgia, |
||||
ZOLEDRONIC ACID, OXYCODONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 1325 | 26691269 |
GB |
||
Peripheral swelling, Joint swelling, Gait disturbance, Tendon discomfort, Musculoskeletal stiffness, Pain, Condition aggravated, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, NAPROXEN, NAPROXEN SODIUM, |
||||
| 1326 | 26691288 |
US |
69 | 2 |
Gait disturbance, Blood pressure abnormal, Asthenia, |
||||
VANDETANIB, |
||||
| 1327 | 26691292 |
US |
2 | |
Gait disturbance, Pain, Pain in extremity, Product use in unapproved indication, |
||||
SARILUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, EPINEPHRINE, ADRENALINUM, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FENOFIBRATE, GABAPENTIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 1328 | 26691545 |
CN |
1 | |
Cafe au lait spots, Gait disturbance, Muscular weakness, Breath sounds abnormal, |
||||
SELUMETINIB, |
||||
| 1329 | 26691815 |
EU |
37 | 1 |
Gait disturbance, Limb discomfort, Tachycardia paroxysmal, Vertigo, Withdrawal syndrome, Drug use disorder, |
||||
BACLOFEN, BACLOFEN, BACLOFEN, |
||||
| 1330 | 26691931 |
AR |
2 | |
Metastases to bone, Groin pain, Gait disturbance, Diarrhoea, |
||||
FULVESTRANT, FULVESTRANT, RIBOCICLIB, ENALAPRIL MALEATE, ENALAPRIL, ROSUVASTATIN, |
||||
| 1331 | 26692691 |
EU |
43 | 2 |
Mental impairment, Somnolence, Disturbance in attention, Fatigue, Gait disturbance, Headache, |
||||
ACYCLOVIR, |
||||
| 1332 | 26692879 |
US |
2 | |
Colostomy bag user, Bone cancer, Arthritis, Gait disturbance, |
||||
ETANERCEPT, |
||||
| 1333 | 26692948 |
62 | 2 | |
Myalgia, Arthralgia, Gait disturbance, Therapy cessation, |
||||
ROSUVASTATIN CALCIUM, LISINOPRIL, LEVOTHYROXINE SODIUM, |
||||
| 1334 | 26693116 |
US |
2 | |
Cyst, Cyst drainage, Gait disturbance, Pain in extremity, |
||||
DENOSUMAB, |
||||
| 1335 | 26693176 |
1 | ||
Headache, Influenza, Dehydration, Blood potassium decreased, Gait disturbance, Therapy interrupted, Fatigue, Eye disorder, |
||||
| 1336 | 26693187 |
CA |
43 | 2 |
Pericarditis, Wound, Live birth, Dyspnoea, Depression, Type 2 diabetes mellitus, Delirium, Bursitis, Blood cholesterol increased, C-reactive protein abnormal, Duodenal ulcer perforation, Abdominal discomfort, Rash, Diarrhoea, Hypoaesthesia, Asthenia, Alopecia, Helicobacter infection, Gait disturbance, Pemphigus, Hypertension, Fatigue, Decreased appetite, Glossodynia, Swelling, Drug intolerance, Hand deformity, |
||||
SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, QUETIAPINE FUMARATE, QUETIAPINE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ERENUMAB-AOOE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, CANDESARTAN, OXYCODONE HYDROCHLORIDE, OXYCODONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, INFLIXIMAB, LAMOTRIGINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RAMIPRIL, TOPIRAMATE, TOPIRAMATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, |
||||
| 1337 | 26693308 |
US |
70 | 2 |
Fall, Hip fracture, Gait disturbance, Arthralgia, Cough, Nasopharyngitis, Hypoaesthesia, Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 1338 | 26693364 |
CA |
60 | 1 |
Acne, Back pain, Balance disorder, COVID-19, Fall, Fatigue, Gait disturbance, Hyperhidrosis, Memory impairment, Muscular weakness, Sciatic nerve injury, Skin cancer, |
||||
FINGOLIMOD HYDROCHLORIDE, FINGOLIMOD HYDROCHLORIDE, ERGOCALCIFEROL, |
||||
| 1339 | 26693411 |
EU |
65 | 1 |
Paralysis, Gait inability, Product use in unapproved indication, Gait disturbance, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
| 1340 | 26693427 |
CA |
81 | 1 |
Myelopathy, Spinal cord compression, Off label use, Dysuria, Urinary tract infection, Pharyngitis, Gait disturbance, Pain in extremity, Spinal disorder, |
||||
INFLIXIMAB-AXXQ, INFLIXIMAB-AXXQ, INFLIXIMAB-AXXQ, INFLIXIMAB-AXXQ, INFLIXIMAB-AXXQ, |
||||
| 1341 | 26693818 |
2 | ||
Shock, Cardiac flutter, Cardiac disorder, Ingrowing nail, Nausea, Abdominal pain, Paraesthesia, Muscle spasms, Fatigue, Malaise, Asthenia, Headache, Dyspnoea, Immediate post-injection reaction, Cough, Procedural pain, Palpitations, Angina pectoris, Abdominal discomfort, Gait disturbance, Lethargy, Contrast media reaction, Rhinorrhoea, Hypotension, Pain, Lung disorder, Bladder disorder, Liver disorder, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 1342 | 26694110 |
BR |
72 | 2 |
Cardiac arrest, Pulmonary necrosis, Dyspnoea, Exposure via skin contact, Gait disturbance, Lung disorder, Asthenia, Accidental exposure to product, Product dose omission issue, Product complaint, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, |
||||
| 1343 | 26694390 |
US |
||
Hospitalisation, Asthenia, Hypokinesia, Gait disturbance, Hand deformity, Hypoaesthesia, Illness, Headache, Muscle spasms, Muscular weakness, Gait inability, Fatigue, Unevaluable event, Product dose omission issue, |
||||
VUTRISIRAN, |
||||
| 1344 | 26694934 |
US |
2 | |
Gait disturbance, Off label use, |
||||
PACRITINIB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FUROSEMIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, NADOLOL, ASCIMINIB, SPIRONOLACTONE, LEVOTHYROXINE SODIUM, |
||||
| 1345 | 26694971 |
US |
74 | 2 |
Glaucoma, Rash, Dry mouth, Constipation, Inflammation, Sensitive skin, Skin discolouration, Pain in extremity, Gait disturbance, Peripheral swelling, Fall, Insomnia, Musculoskeletal stiffness, |
||||
DURVALUMAB, |
||||
| 1346 | 26694991 |
US |
2 | |
Rectal haemorrhage, Headache, Musculoskeletal stiffness, Musculoskeletal discomfort, Thinking abnormal, Apathy, Social avoidant behaviour, Laziness, Brain fog, Gait disturbance, Constipation, Somnolence, Musculoskeletal chest pain, Back pain, Fatigue, Paraesthesia, Haemorrhoids, Fall, |
||||
RAVULIZUMAB, RAVULIZUMAB, POLYETHYLENE GLYCOL 3350, |
||||
| 1347 | 26681864 |
EU |
68 | 2 |
Dizziness, Hyperkinesia, On and off phenomenon, Parkinsonian gait, Insomnia, Wrong technique in device usage process, Hypokinesia, Muscle spasms, Emotional disorder, Malaise, Gait disturbance, Mobility decreased, Hemiparesis, Multiple sclerosis, On and off phenomenon, Therapeutic product effect variable, Dyskinesia, Fine motor skill dysfunction, Speech disorder, Device use error, Cerebrovascular accident, Motor dysfunction, Cerebrovascular accident, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, CANDESARTAN, OPICAPONE, SIPONIMOD, |
||||
| 1348 | 26681885 |
US |
50 | 2 |
Cerebrovascular accident, Transient ischaemic attack, Taste disorder, Gait disturbance, Vision blurred, Tinnitus, Blood pressure abnormal, |
||||
RISANKIZUMAB-RZAA, |
||||
| 1349 | 26681939 |
US |
59 | 2 |
Asthma, Nasopharyngitis, Gait disturbance, Coronary artery disease, Snoring, Obstructive sleep apnoea syndrome, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ATORVASTATIN CALCIUM, CARISOPRODOL, CLONAZEPAM, ESCITALOPRAM, CONJUGATED ESTROGENS, ESTROGENS, CONJUGATED, EVOLOCUMAB, FUROSEMIDE, GABAPENTIN, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, LEVOTHYROXINE SODIUM, MONTELUKAST SODIUM, ZOLPIDEM TARTRATE, |
||||
| 1350 | 26682107 |
71 | ||
Neuropathy peripheral, Eyelid ptosis, Balance disorder, Gait disturbance, Vision blurred, |
||||
ROZANOLIXIZUMAB, EFGARTIGIMOD ALFA, |
||||
| 1351 | 26682232 |
CA |
81 | 2 |
Feeling abnormal, Poor quality sleep, Off label use, Gait disturbance, Drug interaction, Dyspnoea, Anaemia, Diarrhoea, Headache, |
||||
CLOPIDOGREL, CLOPIDOGREL BISULFATE, SELEXIPAG, SELEXIPAG, SELEXIPAG, SELEXIPAG, TADALAFIL, |
||||
| 1352 | 26682458 |
US |
17 | 1 |
Sedation complication, Gait disturbance, Off label use, Therapy partial responder, |
||||
LORAZEPAM, LORAZEPAM, PROPRANOLOL HYDROCHLORIDE, AMANTADINE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, |
||||
| 1353 | 26682492 |
US |
1 | |
Dizziness, Disorientation, Gait disturbance, |
||||
DUPILUMAB, CARVEDILOL, FAMOTIDINE, LOSARTAN, TERAZOSIN, TERAZOSIN HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, |
||||
| 1354 | 26682850 |
US |
60 | 2 |
Diabetes mellitus, Dry mouth, Back pain, Gait disturbance, Weight decreased, Myalgia, Arthralgia, |
||||
TERIPARATIDE, |
||||
| 1355 | 26683088 |
US |
74 | 2 |
Insomnia, Pruritus, Gait disturbance, |
||||
DUPILUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL, ALLOPURINOL, BIOTIN, CARVEDILOL, ERGOCALCIFEROL, |
||||
| 1356 | 26683438 |
US |
21 | 1 |
Dizziness, Gait disturbance, Anxiety, Slow speech, Blood glucose decreased, |
||||
INSULIN LISPRO, |
||||
| 1357 | 26683974 |
US |
1 | |
Feeling abnormal, Eating disorder, Sleep disorder, Gait disturbance, Nausea, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 1358 | 26683988 |
US |
2 | |
Chills, Gait disturbance, Drug ineffective, Product quality issue, Fatigue, Diabetes mellitus inadequate control, Product use in unapproved indication, |
||||
ORAL SEMAGLUTIDE, |
||||
| 1359 | 26684204 |
US |
2 | |
Gait disturbance, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 1360 | 26684243 |
US |
1 | |
Gait disturbance, Neck pain, |
||||
ORAL SEMAGLUTIDE, |
||||
| 1361 | 26685513 |
US |
2 | |
Product storage error, Gait disturbance, Therapeutic response shortened, Joint swelling, |
||||
ADALIMUMAB, |
||||
| 1362 | 26685729 |
US |
1 | |
Visual impairment, Gait disturbance, Blood glucose increased, Wrong product administered, |
||||
INSULIN ASPART, INSULIN ASPART, INSULIN GLARGINE, |
||||
| 1363 | 26685761 |
US |
2 | |
Gait disturbance, Weight increased, |
||||
| 1364 | 26685891 |
EG |
42 | 2 |
Multiple sclerosis relapse, Dyspnoea, Body temperature increased, Plasmapheresis, Gait disturbance, Limb discomfort, Deafness, Vision blurred, |
||||
OCRELIZUMAB, HYDROCORTISONE, |
||||
| 1365 | 26686342 |
MX |
63 | 2 |
Renal disorder, Liver disorder, Vomiting, Diarrhoea, Breast cancer, Organ failure, Kidney infection, Hepatic infection bacterial, General physical health deterioration, Visual impairment, Cognitive disorder, Ill-defined disorder, Aphasia, Ataxia, Dislocation of vertebra, Diarrhoea, Pain in extremity, Fatigue, Fall, Gait disturbance, Anaemia, White blood cell count decreased, Platelet count decreased, Neck pain, Vomiting, Diarrhoea, Hypophagia, Anaemia, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, FULVESTRANT, FULVESTRANT, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LINAGLIPTIN, LORATADINE, LORATADINE ORAL, HYDROCHLOROTHIAZIDE, LOSARTAN, LOSARTAN, GLYBURIDE, |
||||
| 1366 | 26687379 |
US |
80 | |
Rib fracture, Fall, Gait disturbance, Hypokinesia, Cough, Musculoskeletal chest pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 1367 | 26687711 |
ZA |
59 | 1 |
Multiple sclerosis relapse, Multiple sclerosis, Gait disturbance, Balance disorder, Fall, |
||||
FINGOLIMOD HYDROCHLORIDE, |
||||
| 1368 | 26687745 |
CN |
81 | 1 |
Dizziness, Asthenia, Gait disturbance, Blood pressure decreased, Hypovolaemic shock, Arrhythmia, Discomfort, Heart sounds abnormal, Pulse abnormal, |
||||
| 1369 | 26687839 |
CA |
56 | 2 |
Diabetes mellitus, Condition aggravated, Rheumatoid arthritis, Pemphigus, Hypersensitivity, Fatigue, Swelling, Vomiting, Oedema, Urticaria, Psoriatic arthropathy, Fibromyalgia, Treatment failure, Wheezing, Gait disturbance, Systemic lupus erythematosus, Peripheral swelling, Dislocation of vertebra, Maternal exposure during pregnancy, Prescribed overdose, Nausea, Rash, Alopecia, Arthropathy, Muscular weakness, Drug intolerance, |
||||
SECUKINUMAB, DICLOFENAC SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ETANERCEPT, LEFLUNOMIDE, RITUXIMAB, TOCILIZUMAB, CELECOXIB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, LEFLUNOMIDE, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, DESOXIMETASONE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOFACITINIB CITRATE, TOFACITINIB CITRATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, CORTISONE ACETATE, ADALIMUMAB, CERTOLIZUMAB PEGOL, INFLIXIMAB, TOFACITINIB, TOFACITINIB CITRATE, SULFASALAZINE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, CALCIUM, |
||||
| 1370 | 26688021 |
US |
1 | |
Upper limb fracture, Fall, Gait disturbance, |
||||
ACALABRUTINIB, |
||||
| 1371 | 26688256 |
US |
78 | 1 |
Pain in extremity, Fatigue, Gait disturbance, Sinus congestion, Brain fog, |
||||
INCLISIRAN, |
||||
| 1372 | 26688295 |
EU |
74 | 1 |
General physical health deterioration, Hypocalcaemia, On and off phenomenon, Gait disturbance, Fall, Fall, Balance disorder, Diarrhoea, Petechiae, Anaemia, Contusion, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 1373 | 26688307 |
57 | 2 | |
Rheumatoid arthritis, Limb discomfort, Gait disturbance, Pain, Frustration tolerance decreased, Malaise, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 1374 | 26688319 |
2 | ||
Malignant melanoma, Melanocytic naevus, Gait disturbance, Platelet count decreased, Myalgia, Fatigue, |
||||
REPOSITORY CORTICOTROPIN, REPOSITORY CORTICOTROPIN, PREDNISONE, |
||||
| 1375 | 26688546 |
1 | ||
Major depression, Gait disturbance, Dizziness, |
||||
TENOFOVIR ALAFENAMIDE, |
||||
| 1376 | 26688659 |
US |
62 | 1 |
Contusion, Gouty arthritis, Paraesthesia, Gait disturbance, Swelling, |
||||
ADALIMUMAB, |
||||
| 1377 | 26688670 |
82 | 2 | |
Musculoskeletal pain, Pain, Arthralgia, Pain in extremity, Swelling, Erythema, Burning sensation, Dysstasia, Sitting disability, Gait disturbance, Hypersensitivity, Overdose, |
||||
DENOSUMAB, DENOSUMAB, |
||||
| 1378 | 26688737 |
US |
30 | 2 |
Uveitis, Drug ineffective, Gait disturbance, Blood cholesterol increased, Acne cystic, Dizziness, |
||||
TOFACITINIB, |
||||
| 1379 | 26688799 |
US |
||
Blister, Arthropathy, Gait disturbance, Vision blurred, |
||||
VORICONAZOLE, VORICONAZOLE INJECTION, |
||||
| 1380 | 26689140 |
AU |
1 | |
Cerebellar stroke, Gait disturbance, Hyporesponsive to stimuli, Hypotension, Micturition urgency, Neuralgia, Neuropathy peripheral, Nocturia, On and off phenomenon, Presyncope, Speech disorder, Abdominal distension, Balance disorder, Binocular eye movement disorder, Cerebral hypoperfusion, Constipation, Depression, Diplopia, Dizziness, Dysarthria, Dysphonia, Feeling cold, Frustration tolerance decreased, General symptom, Slow response to stimuli, |
||||
AMANTADINE HYDROCHLORIDE, APOMORPHINE HYDROCHLORIDE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, RABEPRAZOLE SODIUM, RABEPRAZOLE, RASAGILINE MESYLATE, SOLIFENACIN SUCCIATE, SOLIFENACIN SUCCINATE, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, RIVAROXABAN, FUROSEMIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, NORTRIPTYLINE HYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE, PREGABALIN, |
||||
| 1381 | 26676638 |
CA |
43 | 2 |
Deep vein thrombosis postoperative, Gastrointestinal disorder, Overdose, Dizziness, Decreased appetite, Glossodynia, Diarrhoea, Gait disturbance, Depression, Off label use, Discomfort, Contraindicated product administered, Drug intolerance, General physical health deterioration, Dyspnoea, Facet joint syndrome, Dry mouth, Drug hypersensitivity, Dyspepsia, Grip strength decreased, Duodenal ulcer perforation, Confusional state, Delirium, Dislocation of vertebra, Gait inability, |
||||
DICLOFENAC, DICLOFENAC SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, SECUKINUMAB, SECUKINUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, CELECOXIB, CELECOXIB, CELECOXIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREGABALIN, APREMILAST, APREMILAST, APREMILAST, RISEDRONATE SODIUM, RISEDRONATE SODIUM, APREMILAST, OXYCODONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB CITRATE, USTEKINUMAB, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
| 1382 | 26676641 |
US |
57 | 2 |
Foot operation, Contusion, Peripheral swelling, Peripheral swelling, Gait disturbance, Pain in extremity, Psoriasis, Joint stiffness, Musculoskeletal stiffness, Tendon disorder, |
||||
UPADACITINIB, UPADACITINIB, PROPRANOLOL HYDROCHLORIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, LOSARTAN, LEVOTHYROXINE SODIUM, ESTRADIOL, |
||||
| 1383 | 26677066 |
US |
1 | |
Hallucination, Gait disturbance, Confusional state, Oedema peripheral, Constipation, |
||||
PIMAVANSERIN TARTRATE, DULOXETINE HYDROCHLORIDE, DULOXETINE, FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 1384 | 26677121 |
US |
2 | |
Condition aggravated, Gait disturbance, Underdose, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, FOLIC ACID, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM, LOSARTAN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, RIVASTIGMINE, SIMVASTATIN, |
||||
| 1385 | 26677189 |
US |
79 | 1 |
Mental impairment, Gait disturbance, Brain fog, Malaise, Feeling abnormal, Disturbance in attention, Dizziness, Fatigue, Hot flush, Asthenia, |
||||
RELUGOLIX, RELUGOLIX, ALBUTEROL SULFATE, ALBUTEROL, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, EZETIMIBE, CYANOCOBALAMIN, GABAPENTIN, LORAZEPAM, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, LATANOPROST, NITROGLYCERIN, OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE, OXYBUTYNIN, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ERGOCALCIFEROL, ENZALUTAMIDE, EZETIMIBE, |
||||
| 1386 | 26677301 |
US |
||
Gait disturbance, |
||||
OCRELIZUMAB, UBLITUXIMAB, |
||||
| 1387 | 26677400 |
US |
52 | 2 |
Melaena, Abdominal pain upper, Abdominal pain, Vomiting, Musculoskeletal pain, Dehydration, Gait disturbance, Muscle spasms, Pain, |
||||
SARILUMAB, OLMESARTAN MEDOXOMIL, DICYCLOMINE HYDROCHLORIDE, FERROUS SULFATE, FOLIC ACID, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METHOCARBAMOL, METHOCARBAMOL TABLETS, METHOTREXATE, METHOTREXATE SODIUM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ONDANSETRON HYDROCHLORIDE, THYROID, IODIUM,BADIAGA,FUCUS VESICULOSUS,CALCAREAARSENICUM IODATUM, THYROIDINUM,CARBONICA,PULSATILLA,BARYTA CARBONICA,, TOPIRAMATE, UBROGEPANT, ERGOCALCIFEROL, BUPROPION HYDROCHLORIDE, TIRZEPATIDE, |
||||
| 1388 | 26677669 |
US |
28 | 2 |
Joint swelling, Gait disturbance, Skin warm, Joint stiffness, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, |
||||
| 1389 | 26678180 |
EU |
22 | 2 |
Neuroleptic malignant syndrome, Dystonia, Muscle contractions involuntary, Muscle twitching, Body temperature increased, Creatine kinase increased, Tremor, Muscle tightness, Gait disturbance, Musculoskeletal stiffness, Product use in unapproved indication, |
||||
OLANZAPINE, OLANZAPINE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, SERTRALINE, SERTRALINE, |
||||
| 1390 | 26678260 |
GB |
74 | |
Inappropriate schedule of product administration, Cerebrovascular accident, Hypoaesthesia, Balance disorder, Confusional state, Fall, Malaise, Limb discomfort, Gait disturbance, Musculoskeletal chest pain, Productive cough, Feeling cold, Chromaturia, Pyrexia, Decreased appetite, Neutrophil count abnormal, |
||||
METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, RIVAROXABAN, RIVAROXABAN, RIVAROXABAN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACYCLOVIR, ACYCLOVIR, IXAZOMIB, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, CEPHALEXIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 1391 | 26678389 |
US |
89 | 1 |
Hallucination, Fine motor skill dysfunction, Condition aggravated, Gait disturbance, Confusional state, Condition aggravated, Anxiety, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, DIGOXIN, DONEPEZIL HYDROCHLORIDE, LISINOPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, RIVAROXABAN, |
||||
| 1392 | 26678411 |
US |
2 | |
Drooling, Fear, Condition aggravated, Nervousness, Gait disturbance, Anxiety, |
||||
TROFINETIDE, |
||||
| 1393 | 26678505 |
CO |
86 | 2 |
Syncope, Gait disturbance, Pain in extremity, Arthralgia, Myalgia, Renal pain, Unevaluable event, |
||||
DENOSUMAB, |
||||
| 1394 | 26678784 |
CA |
43 | 2 |
Pericarditis, Wound, Live birth, Dyspnoea, Depression, Type 2 diabetes mellitus, Delirium, Bursitis, Blood cholesterol increased, C-reactive protein abnormal, Duodenal ulcer perforation, Abdominal discomfort, Rash, Diarrhoea, Hypoaesthesia, Asthenia, Alopecia, Helicobacter infection, Gait disturbance, Pemphigus, Hypertension, Fatigue, Decreased appetite, Glossodynia, Swelling, Drug intolerance, Hand deformity, Adjustment disorder with depressed mood, Maternal exposure during pregnancy, Dislocation of vertebra, Synovitis, Arthralgia, Intentional product use issue, Discomfort, Anti-cyclic citrullinated peptide antibody positive, Arthropathy, Hepatic enzyme increased, Wheezing, Abdominal pain, Amnesia, General physical health deterioration, Fibromyalgia, Grip strength decreased, Condition aggravated, Drug hypersensitivity, Wound infection, Breast cancer stage III, Dry mouth, Vomiting, Blister, Systemic lupus erythematosus, Anxiety, Ear pain, Joint range of motion decreased, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ALENDRONATE SODIUM, ALENDRONATE SODIUM, CANDESARTAN, SECUKINUMAB, SECUKINUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, INFLIXIMAB, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, TOPIRAMATE, TOPIRAMATE, ERENUMAB-AOOE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 1395 | 26679116 |
US |
2 | |
Pain, Lymphadenopathy, Condition aggravated, Injection site pain, Injection site swelling, Gait disturbance, Incorrect dose administered, |
||||
DUPILUMAB, LORATADINE, LORATADINE TABLET, CYCLOSPORINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OLOPATADINE HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 1396 | 26679158 |
EU |
43 | 2 |
Mental impairment, Somnolence, Disturbance in attention, Fatigue, Gait disturbance, Headache, |
||||
ACYCLOVIR, |
||||
| 1397 | 26679557 |
US |
1 | |
Multiple organ dysfunction syndrome, Immunodeficiency common variable, Leukopenia, Oesophageal candidiasis, Herpes simplex oesophagitis, Pharyngeal abscess, Listeriosis, Deafness, Pachymeningitis, Blindness, Colitis, Basal ganglia stroke, Gene mutation, Lymphopenia, Skin lesion, Granuloma, Skin ulcer, Infection, Papilloma viral infection, Arthralgia, Gait disturbance, Balance disorder, Arthritis, Ageusia, Anosmia, Hepatic lesion, Off label use, Product ineffective for unapproved use, |
||||
ETANERCEPT, ETANERCEPT, PREDNISONE, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, RIBAVIRIN, NITAZOXANIDE, TOFACITINIB CITRATE, |
||||
| 1398 | 26679631 |
US |
2 | |
Autoimmune disorder, Multiple sclerosis, Gait disturbance, |
||||
DALFAMPRIDINE, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, BACLOFEN, BIOTIN, CALCIUM CARBONATE, ANTACID, GABAPENTIN, IRON, LISINOPRIL, LORATADINE, LORATADINE ORAL, MAGNESIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, CANNABIDIOL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, PROPRANOLOL HYDROCHLORIDE, ASCORBIC ACID, ERGOCALCIFEROL, |
||||
| 1399 | 26679693 |
65 | 2 | |
Blood glucose decreased, Nervousness, Illness, Immune system disorder, Gait disturbance, Malaise, Asthenia, Product dose omission issue, Incorrect dose administered, |
||||
REPOSITORY CORTICOTROPIN, PREDNISONE, PREDNISONE, |
||||
| 1400 | 26679712 |
2 | ||
Chronic kidney disease, Hypertension, Thyroid disorder, Gait disturbance, Weight decreased, Insomnia, Headache, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30